{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:04:15Z","timestamp":1760853855746},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,4,22]],"date-time":"2015-04-22T00:00:00Z","timestamp":1429660800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12936-015-0684-5","type":"journal-article","created":{"date-parts":[[2015,4,20]],"date-time":"2015-04-20T21:24:56Z","timestamp":1429565096000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Simultaneous quantification of proposed anti-malarial combination comprising of lumefantrine and CDRI 97\u201378 in rat plasma using the HPLC\u2013ESI-MS\/MS method: application to drug interaction study"],"prefix":"10.1186","volume":"14","author":[{"given":"Muhammad","family":"Wahajuddin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheelendra P","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isha","family":"Taneja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanumuri SR","family":"Raju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaur R","family":"Gayen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hefazat H","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shio K","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,4,22]]},"reference":[{"key":"684_CR1","volume-title":"World malaria report 2013","author":"WHO","year":"2013","unstructured":"WHO. World malaria report 2013. Geneva: World Health Organization; 2013."},{"key":"684_CR2","doi-asserted-by":"crossref","unstructured":"Wahajuddin, Singh SP, Singh SK, Jain GK. Quantitation of Lumefantrine in Biological Matrices. Cur Pharm Anal. 2011; 7:42-6.","DOI":"10.2174\/157341211794708730"},{"key":"684_CR3","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.trac.2012.09.014","volume":"42","author":"Wahajuddin","year":"2013","unstructured":"Wahajuddin, Raju KSR, Taneja I. Bioanalysis of antimalarials using liquid chromatography. Trends Analyt Chem. 2013;42:186\u2013204.","journal-title":"Trends Analyt Chem"},{"key":"684_CR4","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMoa0808859","volume":"361","author":"AM Dondorp","year":"2009","unstructured":"Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009;361:455\u201367.","journal-title":"N Engl J Med"},{"key":"684_CR5","unstructured":"Singh C, Malik H, Puri SK: Spiro-1, 2, 4-trioxanes. US Patent 7495025 B2. 2009."},{"key":"684_CR6","unstructured":"Singh C, Puri SK. Substituted 1, 2, 4-trioxanes as antimalarial agents and a process of producing the substituted 1, 2, 4-trioxanes. US Patent 6316493 B1,2001."},{"key":"684_CR7","first-page":"372521","volume":"2014","author":"N Shafiq","year":"2014","unstructured":"Shafiq N, Rajagopalan S, Kushwaha HN, Mittal N, Chandurkar N, Bhalla A, et al. Single ascending dose safety and pharmacokinetics of CDRI-97\/78: first-in-human study of a novel antimalarial drug. Malar Res Treat. 2014;2014:372521.","journal-title":"Malar Res Treat"},{"key":"684_CR8","first-page":"120","volume":"61","author":"RP Singh","year":"2011","unstructured":"Singh RP, Sabarinath S, Gautam N, Gupta RC, Singh SK. Pharmacokinetic study of the novel, synthetic trioxane antimalarial compound 97\u201378 in rats using an LC-MS\/MS method for quantification. Arzneimittel-Forschung. 2011;61:120\u20135.","journal-title":"Arzneimittel-Forschung"},{"key":"684_CR9","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.jchromb.2009.02.058","volume":"877","author":"Wahajuddin","year":"2009","unstructured":"Wahajuddin, Singh SP, Jain GK. Determination of lumefantrine in rat plasma by liquid-liquid extraction using LC-MS\/MS with electrospray ionization: assay development, validation and application to a pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci. 2009;877:1133\u20139.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"684_CR10","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/bdd.1786","volume":"33","author":"Wahajuddin","year":"2012","unstructured":"Wahajuddin, Singh SP, Jain GK. Gender differences in pharmacokinetics of lumefantrine and its metabolite desbutyl-lumefantrine in rats. Biopharm Drug Dispos. 2012;33:229\u201334.","journal-title":"Biopharm Drug Dispos"},{"key":"684_CR11","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/1475-2875-10-293","volume":"10","author":"Wahajuddin","year":"2011","unstructured":"Wahajuddin, Singh SP, Raju KSR, Nafis A, Puri SK, Jain GK. Intravenous pharmacokinetics, oral bioavailability, dose proportionality and in situ permeability of anti-malarial lumefantrine in rats. Malar J. 2011;10:293.","journal-title":"Malar J"},{"key":"684_CR12","volume-title":"Guidance for industry: bioanalytical method validation","author":"US FDA","year":"2013","unstructured":"US FDA. Guidance for industry: bioanalytical method validation. Rockville, MD: CDER; 2013."}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-015-0684-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12936-015-0684-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-015-0684-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-015-0684-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T18:39:58Z","timestamp":1553625598000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-015-0684-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,22]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["684"],"URL":"https:\/\/doi.org\/10.1186\/s12936-015-0684-5","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,22]]},"assertion":[{"value":"26 November 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"172"}}